These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22654918)

  • 1. Drug discovery models and toxicity testing using embryonic and induced pluripotent stem-cell-derived cardiac and neuronal cells.
    Deshmukh RS; Kovács KA; Dinnyés A
    Stem Cells Int; 2012; 2012():379569. PubMed ID: 22654918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in iPSC technologies involving cardiovascular and neurodegenerative disease modeling.
    Csöbönyeiová M; Danišovič Ľ; Polák Š
    Gen Physiol Biophys; 2016 Jan; 35(1):1-12. PubMed ID: 26492069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.
    Singh VK; Kalsan M; Kumar N; Saini A; Chandra R
    Front Cell Dev Biol; 2015; 3():2. PubMed ID: 25699255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential applications of induced pluripotent stem cells (iPSCs) in hepatology research.
    Sun C; Wilson GS; Fan JG; Qiao L
    Curr Stem Cell Res Ther; 2015; 10(3):208-15. PubMed ID: 25599714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells.
    Koehler KR; Tropel P; Theile JW; Kondo T; Cummins TR; Viville S; Hashino E
    BMC Neurosci; 2011 Aug; 12():82. PubMed ID: 21831300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.
    Bai Q; Desprat R; Klein B; Lemaître JM; De Vos J
    Curr Gene Ther; 2013 Apr; 13(2):93-8. PubMed ID: 23317057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of mice derived from induced pluripotent stem cells.
    Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
    J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.
    Csöbönyeiová M; Polák Š; Danišovič L
    Exp Biol Med (Maywood); 2015 May; 240(5):549-56. PubMed ID: 25595188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature.
    Quattrocelli M; Thorrez L; Sampaolesi M
    Recent Pat Drug Deliv Formul; 2013 Apr; 7(1):18-28. PubMed ID: 22974171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.
    Hu S; Zhao MT; Jahanbani F; Shao NY; Lee WH; Chen H; Snyder MP; Wu JC
    JCI Insight; 2016 Jun; 1(8):. PubMed ID: 27398408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
    Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.
    Haridhasapavalan KK; Borgohain MP; Dey C; Saha B; Narayan G; Kumar S; Thummer RP
    Gene; 2019 Feb; 686():146-159. PubMed ID: 30472380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.
    Montgomery A; Wong A; Gabers N; Willerth SM
    Biomater Sci; 2015 Feb; 3(2):401-13. PubMed ID: 26218131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.
    Kramer AS; Harvey AR; Plant GW; Hodgetts SI
    Cell Transplant; 2013; 22(4):571-617. PubMed ID: 22944020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.